Michel Bouvier

This inventor holds 13 USPTO granted patents and 6 published patent applications, plus 14 CIPO patents and 5 EPO patents. Top assignees: Universitéde Montreal, Valorisation-Recherche, Limited Partnership, Amicus Therapeutics, Inc.. Active years: 2004-2020.

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 76.9

CIPO Patents = 14

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 16(Granted Patents)

Location History:

Montreal, CA (2011 - 2019)
Montréal, CA (2004 - 2020)

Company Filing History:

8 out of 189

Universitéde Montreal

patents

3 out of 43

Valorisation-Recherche, Limited Partnership

patents

2 out of 161

Amicus Therapeutics, Inc.

patents

4. 2 out of 5,383

Centre National De La Recherche Scientifique

6. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10877036 - Biosensor based on Gβγ-interacting proteins to monitor G-protein activation (2020-12-29),

2. 10584159 - Renilla based biosensors for monitoring biomolecule localization and trafficking in cells (2020-03-10),

3. 10324085 - Systems and methods for the monitoring of protein complex formation in cells (2019-06-18),

4. 9937165 - Pharmacological chaperones for treating obesity (2018-04-10),

5. 9493456 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators (2016-11-15),

6. 9381194 - Pharmacological chaperones for treating obesity (2016-07-05),

7. 9029097 - Biosensors for monitoring receptor-mediated G-protein activation (2015-05-12),

8. 9018395 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators (2015-04-28),

9. 8883486 - Arrestin biosensor (2014-11-11),

10. 7932080 - Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same (2011-04-26),

11. 7439030 - Preparing membrane receptors from extracellular baculoviruses (2008-10-21),

12. 7078189 - Preparing membrane receptors from extracellular baciloviruses (2006-07-18),

13. 6713278 - Preparing membrane receptors from extracellular baculoviruses (2004-03-30),

Title: Inventor Michel Bouvier - Revolutionizing the World of Inventions

Introduction: Michel Bouvier, a distinguished inventor hailing from Montreal, Canada, has made significant contributions to the field of innovations with his groundbreaking ideas and creations.

Latest Patents: Bouvier's latest patents include cutting-edge technologies in the fields of biotechnology, pharmaceuticals, and sustainable energy solutions, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Bouvier has been recognized for his innovative spirit and problem-solving abilities, leading to the development of numerous patented inventions that have had a profound impact on various industries.

Collaborations: Bouvier has collaborated with leading research institutions, universities, and companies worldwide to further his inventions and bring them to market, demonstrating his commitment to driving progress and fostering innovation.

Conclusion: Michel Bouvier's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.